- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02192528
Vitamin D and Outcome in Cardiac Surgery (Calcitop)
August 10, 2016 updated by: Heart and Diabetes Center North-Rhine Westfalia
25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D and Postoperative Outcome in Cardiac Surgical Patients
We will use a retrospective data analysis to evaluate the association of the two vitamin D metabolites 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D with clinical outcome in cardiac surgical patients.
The occurrence of several postoperative adverse events such as myocardial infarction, low cardiac output syndrome, stroke and in-hospital death will be assessed from cardiac surgery to discharge.
In addition, we will assess the association of the two vitamin D metaboolites with the duration of mechanical ventilatory support and intensive care unit stay from cardiac surgery to discharge.
Moreover, in-hospital stay will be assessed according to vitamin D metabolite levels.
Study Overview
Status
Completed
Conditions
Detailed Description
In a retrospective data analysis, we will evaluate the association of vitamin D metabolites (circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D) with MACCE (major cardiac or cerebrovascular event) in cardiac surgical patients.
The occurrence of several postoperative adverse events such as myocardial infarction, low cardiac output syndrome, stroke and in-hospital death will be assessed from cardiac surgery to discharge.
Approximately 4,000 data sets from mid of 2012 until the end of 2013 will be analyzed.
In all patients, we will also assess the association of vitamin D metabolite levels with the duration of mechanical ventilatory support and intensive care unit stay from cardiac surgery to discharge.
Moreover, in-hospital stay will be assessed according to vitamin D status
Study Type
Observational
Enrollment (Actual)
3852
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
NRW
-
Bad Oeynhausen, NRW, Germany, 32545
- Heart & Diabetes Center North-Rhine Westphalia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
cardiac surgical patients
Description
Inclusion Criteria:
- cardiac surgical patients aged 18 years and older
Exclusion Criteria:
- age < 18 years
- heart transplant recipients
- pacemaker or defibrillator implantation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
cardiac surgical patients
patients undergoing a cardiac surgical procedure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
major cardiac or cerebrovascular event (MACCE)
Time Frame: Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
MACCE is defined as in-hospital death, myocardial infarction, low cardiac output syndrome or stroke.
|
Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
duration of ventilatory support
Time Frame: Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
intensive care unit stay
Time Frame: Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
in-hospital stay
Time Frame: Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
infection
Time Frame: Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Patients will be followed for an average time of 14 days from cardiac surgery to discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Armin Zittermann, PhD, Heart & Diabetes Center North-Rhine Westfalia, Germany
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
July 1, 2014
Study Registration Dates
First Submitted
July 15, 2014
First Submitted That Met QC Criteria
July 15, 2014
First Posted (Estimate)
July 16, 2014
Study Record Updates
Last Update Posted (Estimate)
August 11, 2016
Last Update Submitted That Met QC Criteria
August 10, 2016
Last Verified
July 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States